These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27029038)

  • 21. Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance.
    Muscogiuri G; De Martino MC; Negri M; Pivonello C; Simeoli C; Orio F; Pivonello R; Colao A
    Endocrinology; 2017 Jun; 158(6):1527-1532. PubMed ID: 28368448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic diseases and cancer risk.
    Faulds MH; Dahlman-Wright K
    Curr Opin Oncol; 2012 Jan; 24(1):58-61. PubMed ID: 22123235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. INSULIN LIKE GROWTH FACTOR 1 POSSIBLE DEPENDENCE IN PATIENTS WITH METABOLIC SYNDROME OF NODULAR PATHOLOGY OF THE THYROID GLAND.
    Rekvava M; Dundua T; Kobulia M; Javashvili L; Giorgadze E
    Georgian Med News; 2017 Sep; (270):46-50. PubMed ID: 28972482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.
    Agresti R; Meneghini E; Baili P; Minicozzi P; Turco A; Cavallo I; Funaro F; Amash H; Berrino F; Tagliabue E; Sant M
    Breast Cancer Res Treat; 2016 May; 157(1):179-89. PubMed ID: 27117160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.
    Gallagher EJ; LeRoith D
    Ann N Y Acad Sci; 2011 Dec; 1243():54-68. PubMed ID: 22211893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The metabolic syndrome and insulin resistance].
    Kotani K; Kaku K
    Nihon Rinsho; 2005 Aug; 63(8):1485-91. PubMed ID: 16101244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Westernization on the Insulin/IGF-I Signaling Pathway and the Metabolic Syndrome: It Is Time for Change.
    Janssen JAMJL
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The obesity-cancer link: lessons learned from a fatless mouse.
    Hursting SD; Nunez NP; Varticovski L; Vinson C
    Cancer Res; 2007 Mar; 67(6):2391-3. PubMed ID: 17363554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal muscle - A bystander or influencer of metabolic syndrome?
    Richter-Stretton GL; Fenning AS; Vella RK
    Diabetes Metab Syndr; 2020; 14(5):867-875. PubMed ID: 32562864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
    Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A weighty problem: metabolic perturbations and the obesity-cancer link.
    O'Flanagan CH; Bowers LW; Hursting SD
    Horm Mol Biol Clin Investig; 2015 Aug; 23(2):47-57. PubMed ID: 26167982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The etiology of hypertension in the metabolic syndrome part one: an introduction to the history, the concept and the models.
    Sharma V; McNeill JH
    Curr Vasc Pharmacol; 2006 Oct; 4(4):293-304. PubMed ID: 17073699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome.
    Ren J; Anversa P
    Biochem Pharmacol; 2015 Feb; 93(4):409-17. PubMed ID: 25541285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention.
    Pérez-Martín AR; Castro-Eguiluz D; Cetina-Pérez L; Velasco-Torres Y; Bahena-González A; Montes-Servín E; González-Ibarra E; Espinosa-Romero R; Gallardo-Rincón D
    Bosn J Basic Med Sci; 2022 Jul; 22(4):499-510. PubMed ID: 35276057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Roles of metabolic syndrome and insulin resistance in carcinogenesis of colon].
    Lü BJ; Lai MD
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):110-2. PubMed ID: 16630487
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolic syndrome as a risk factor for neurological disorders.
    Farooqui AA; Farooqui T; Panza F; Frisardi V
    Cell Mol Life Sci; 2012 Mar; 69(5):741-62. PubMed ID: 21997383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different response to hypoxia of adipose-derived multipotent cells from obese subjects with and without metabolic syndrome.
    Oliva-Olivera W; Moreno-Indias I; Coín-Aragüez L; Lhamyani S; Alcaide Torres J; Fernández-Veledo S; Vendrell J; Camargo A; El Bekay R; Tinahones FJ
    PLoS One; 2017; 12(11):e0188324. PubMed ID: 29166648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose.
    García-Jiménez C; García-Martínez JM; Chocarro-Calvo A; De la Vieja A
    J Mol Endocrinol; 2014 Feb; 52(1):R51-66. PubMed ID: 24049067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer?
    Aggarwal RR; Ryan CJ; Chan JM
    Urol Oncol; 2013 Jul; 31(5):522-30. PubMed ID: 21658978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.